Abstract
Micropulse laser trabeculoplasty as an adjuvant treatment for uncontrolled open angle glaucoma
Highlights
Glaucoma is the second leading cause of blindness worldwide and the leading cause of irreversible blindness, accounting for 8% of all blindness, affecting an estimated 3.12 million blind people in the world [1]
The mean percentage of intraocular pressure (IOP) reduction was 17.9% and 7 eyes (40%) had IOP reduction greater than 20%
We report on the pressure lowering effect of micropulse laser trabeculoplasty (MLT) in patients with medically uncontrolled open angle glaucoma of Peruvian eyes in Lima, Peru
Summary
Glaucoma is the second leading cause of blindness worldwide and the leading cause of irreversible blindness, accounting for 8% of all blindness, affecting an estimated 3.12 million blind people in the world [1]. The World Heatlh Organization (WHO) estimated that 12.3% of blindness was cause by glaucoma in 2002 [2]. There will be 79.6 million with glaucoma by 2020, and of these, 74% will have Open angle glaucoma (OAG). Women will comprise 55% of OAG, 70% of angle closure glaucoma (ACG), and 59% of all glaucoma in 2010. Bilateral blindness will be present to 5.9 and 5.3 million people in 2020, respectively [3]. We describe the pressure lowering effect of micropulse laser trabeculoplasty (MLT) in patients with medically uncontrolled open angle glaucoma (OAG)
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
